Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Pre-participation screening of young competitive athletes for prevention of sudden cardiac death 3. The Job Market for 2008-2009: Compensation 4. Renal Artery Stenosis 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
Preventing Restenosis after Implantation of Bare Stents with Oral Rapamycin: A Randomized Angiographic and Intravascular Ultrasound Study with a 5-Year Clinical Follow-Up
Cardiology, 11/04/09
Cernigliaro C et al. – Oral rapamycin significantly reduces the incidence of restenosis at follow–up compared to a placebo. The authors believe these findings deserve further testing in larger trials.
Related Articles
A Phase I Study of the Mammalian Target of Rapamycin Inhibitor Sirolimus and MEC Chemotherapy in Relapsed and Refractory Acute Myelogenous Leukemia
Clinical Cancer Research, 10/26/09
Relevance Score: 88%
Current Approaches to the Use of Sirolimus In Renal Transplantation
Transplantation Proceedings, 11/05/09
Relevance Score: 87%
Combined treatment with cisplatin and sirolimus to enhance cell death in human mesothelioma
The Journal of Thoracic and Cardiovascular Surgery, 10/27/09
Relevance Score: 87%
Multiple coronary artery aneurysm formation one year and four years after sirolimus-eluting coronary stent implantation
Cardiovascular Revascularization Medicine, 10/16/09
Relevance Score: 84%
Resolution of late sirolimus-eluting stent thrombosis after tirofiban treatment
Heart and Vessels, 10/07/09
Relevance Score: 84%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Long-Term Risk of Adverse Outcomes and New Malignancies in Patients Treated With Oral Sirolimus for Prevention of Restenosis
JACC - Journal of the American College of Cardiology: Cardiovascular Interventions, 11/24/09
Correlation of paramedic administration of furosemide with emergency physician diagnosis of congestive heart failure
Journal of Emergency Primary Health Care, 11/24/09
Enoxaparin Versus Unfractionated Heparin in Elective Percutaneous Coronary Intervention
JACC - Journal of the American College of Cardiology: Cardiovascular Interventions, 11/24/09
Today in Interventional...keeping you current
Receive free subspecialty "5-minute updates" via email
Enoxaparin Versus Unfractionated Heparin in Elective Percutaneous Coronary Intervention
JACC - Journal of the American College of Cardiology: Cardiovascular Interventions, 11/24/09
Outcomes With Drug-Eluting Versus Bare-Metal Stents in Saphenous Vein Graft Intervention
JACC - Journal of the American College of Cardiology: Cardiovascular Interventions, 11/24/09
Temporal Trends in Patient-Reported Angina at 1 Year After Percutaneous Coronary Revascularization in the Stent Era
Circulation: Cardiovascular Quality and Outcomes, 11/24/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


